Tunicamycin Induces Hepatic Stellate Cell Apoptosis Through Calpain-2/Ca^{2 +}-Dependent Endoplasmic Reticulum Stress...

Area of Science:

• Hepatology
• Cell Biology
• Biochemistry

Background:

• Hepatic stellate cell (HSC) activation is a key driver of liver fibrosis.
• Inducing apoptosis in activated HSCs is crucial for reversing liver fibrosis.
• Understanding mechanisms that promote HSC apoptosis is vital for treating liver diseases like hepatitis, cirrhosis, and liver cancer.

Purpose of the Study:

• To investigate the potential of tunicamycin, an endoplasmic reticulum stress (ERS) inducer, to induce apoptosis in hepatic stellate cells (HSCs).
• To elucidate the molecular pathway involved in tunicamycin-induced HSC apoptosis, focusing on calpain/caspase mediation and intracellular calcium levels.

Main Methods:

• Treatment of HSCs with tunicamycin, a novel ERS inducer.
• Measurement of intracellular Ca²⁺ concentration.
• Assessment of ERS protein (GRP78), apoptosis proteins (caspase-12, Bax), and anti-apoptosis protein (Bcl-2) expression levels.

Main Results:

• Tunicamycin effectively induced apoptosis in HSCs.
• Tunicamycin treatment led to increased intracellular Ca²⁺ concentration.
• Upregulation of GRP78, caspase-12, and Bax was observed, alongside downregulation of Bcl-2.
• The observed effects were linked to the calpain-2/Ca²⁺-dependent ERS pathway.

Conclusions:

• Tunicamycin induces apoptosis in hepatic stellate cells through a mechanism involving endoplasmic reticulum stress and the calpain-2/Ca²⁺ pathway.
• This study highlights a novel therapeutic approach for reversing liver fibrosis by targeting HSC apoptosis.
• The findings have implications for the clinical management of hepatic-fibrosis-related diseases.